🔴 Icecure Medical is trading 15% down in pre-market after Q2 EPS missed estimates

Icecure Medical is trading at $3.00 (-14.60%) in pre-market on August 12, 2026, after first-half earnings reportedly missed estimates.

• Q2 EPS was -$3.11 versus a -$1.53 estimate; revenue was $910,000 versus expectations of $1.48 million.
• First-half revenue grew 45% to $1.8 million, with approximately $12.0 million in cash.
• The earnings release was scheduled before Nasdaq’s open, with a conference call at 10:00 a.m. EDT.